BioPharma Dive
The 185-acre site will be the company s largest single investment to date, with a focus on small-volume parenteral products like vials and prefilled syringes.
BioPharma Dive
The 185-acre site will be the company s largest single investment to date, with a focus on small-volume parenteral products like vials and prefilled syringes.
BioPharma Dive
The 185-acre site will be the company s largest single investment to date, with a focus on small-volume parenteral products like vials and prefilled syringes.